Clinical Trial Update: A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase III study evaluating faropenem for adult community-acquired pneumonia. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Faropenem (faropenem)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Community Acquired Pneumonia | Phase 3 | Status: UNKNOWN